Trial NCT01499667

View at ClinicalTrials.gov 
Org. Study IDs: CFTY720D2324
Secondary IDs: 2011-001442-15

Last trial update was posted on 2014-08-08

MeSH Interventions

Fingolimod Hydrochloride

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)

Stopping Reasons

Based on recent publications, determination of natalizumub washout period was no longer relevant.

Limitations And Caveats

Study was terminated due to new data on nataluzimab washout prior to treatment with other disease modifying treatments. The power to detect statistically significant differences between the washout groups based on the (-)binomial is estimated 30-40%.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID